← Evidence map

ReviewCurrent treatment options in oncology2015

RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data.

Timothy L Cannon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 26050230